Confidential Treatment Order

A confidential treatment order was filed on 21 May 2015. Details are as follows:

UNITED STATES SECURITIES AND EXCHANGE COMMISSION May 21, 2015 ORDER GRANTING CONFIDENTIAL TREATMENT UNDER THE SECURITIES EXCHANGE ACT OF 1934 Biota Pharmaceuticals, Inc. File No. 001-35285 - CF#32527 _____________________ Biota Pharmaceuticals, Inc. submitted an application under Rule 24b-2 requesting confidential treatment for information it excluded from the Exhibits to a Form 10-Q filed on May 8, 2015. Based on representations by Biota Pharmaceuticals, Inc. that this information qualifies as confidential commercial or financial information under the Freedom of Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly disclose it. Accordingly, excluded information from the following exhibit will not be released to the public for the time period specified: Exhibit 2.1 through May 8, 2025 For the Commission, by the Division of Corporation Finance, pursuant to delegated authority: Brent J. Fields Secretary